144 related articles for article (PubMed ID: 19691457)
21. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
22. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
[TBL] [Abstract][Full Text] [Related]
23. The changing epidemiology of viral hepatitis A in Israel.
Green MS; Aharonowitz G; Shohat T; Levine R; Anis E; Slater PE
Isr Med Assoc J; 2001 May; 3(5):347-51. PubMed ID: 11411199
[TBL] [Abstract][Full Text] [Related]
24. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA
Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis A in Jerusalem--the exception that proves the rule?
Stein-Zamir C; Shoob H; Nubani N; Zentner G
Vaccine; 2008 Sep; 26(41):5241-3. PubMed ID: 18691626
[No Abstract] [Full Text] [Related]
27. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
28. Viral hepatitis in Bucharest.
Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
[TBL] [Abstract][Full Text] [Related]
29. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
Erhart LM; Ernst KC
Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
[TBL] [Abstract][Full Text] [Related]
30. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies.
Cotter SM; Sansom S; Long T; Koch E; Kellerman S; Smith F; Averhoff F; Bell BP
J Infect Dis; 2003 Apr; 187(8):1235-40. PubMed ID: 12696002
[TBL] [Abstract][Full Text] [Related]
31. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
Zhuang F; Jiang Q; Gong Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis A in Poland in 2001].
Sitarska-Gołebiowska J; Bielak A
Przegl Epidemiol; 2003; 57(1):129-34. PubMed ID: 12926319
[TBL] [Abstract][Full Text] [Related]
34. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
Das A
Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
[TBL] [Abstract][Full Text] [Related]
35. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
36. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
Chen H; Cantrell CR
Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
[TBL] [Abstract][Full Text] [Related]
38. Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles.
Xu ZY; Wang XY; Liu CQ; Li YT; Zhuang FC
J Viral Hepat; 2008 Oct; 15 Suppl 2():33-7. PubMed ID: 18837831
[TBL] [Abstract][Full Text] [Related]
39. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
40. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
